Edition:
United States

Profile: Cancer Genetics Inc (CGIX.A)

CGIX.A on American Stock Exchange

0.19USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$0.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,047
52-wk High
$1.23
52-wk Low
$0.17

Cancer Genetics, Inc., incorporated on April 8, 1999, is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services and molecular markers. Through its subsidiary, the Company offers preclinical test systems. The Company offers discovery services to the pharmaceutical industry, biotechnology companies and academic research centers.

The Company provides the tools and testing methods for companies and researchers to identify new molecular- and biomarker-based indicators for disease and to determine the pharmacogenomics, toxicity and efficacy of therapeutic candidate compounds. Its discovery services include development of both xenograft and syngeneic animal models, toxicology and genetic toxicology services, pharmacology testing, pathology services, and validation of biomarkers for diseases including cancers. It also provides consulting, guidance and preparation of samples and clinical trial design.

The Company competes with Champions Oncology, JSR Life Sciences, Eurofins Scientific and Explora Biolabs.

Company Address

Cancer Genetics Inc

201 State Rt 17 Fl 2
RUTHERFORD   NJ   07070-2597
P: +1201.5289200
F: +1201.5289201

Company Web Links